Kapola Alpha Johnson, Musoke Rahma, Manayon Glenda Marie, Fussi Hassan Fredrick, Bakari Hafidha Mhando, Ally Haji Mbwana, Salim Swalehe Mustafa, Ally Zuhura Mbwana, Moshi Lynn, Mbwana Mariam Salim, Ramadhani Habib Omari
EMET Healthcare, Dar es Salaam, Tanzania.
Water Mission, Dar es Salaam, Tanzania.
Ann Glob Health. 2025 Jan 24;91(1):4. doi: 10.5334/aogh.4589. eCollection 2025.
Pre‑exposure prophylaxis (PrEP) is an effective measure for preventing human immunodeficiency virus (HIV) infection among people at risk, including adolescents and young adults (AYA). This study evaluates the prevalence of PrEP awareness and endorsement, as well as the factors associated with these outcomes, using data from the 2022 Tanzania Demographic and Health Survey. The analysis included participants aged 15-24 years. Participants were asked whether they had ever heard of daily medication to prevent HIV (PrEP) and whether they approved of daily PrEP use. Demographic characteristics and HIV testing information were also collected. Logistic regression models were used to assess factors associated with PrEP awareness and endorsement, and the weighted prevalence of these outcomes was calculated. A total of 8,268 respondents aged 15-24 years were evaluated, of whom 5,852 (70.9%) were female. Overall, the prevalence of PrEP awareness and endorsement was 6.9% (95% confidence interval [CI] 6.2-7.7) and 5.7% (95% CI 5.1-6.4), respectively. Female respondents (adjusted odds ratio [aOR] = 0.69; 95% CI 0.51-0.91) and rural residents (aOR = 0.78; 95% CI 0.61-1.00) had lower odds of PrEP awareness compared with male respondents and urban residents, respectively. Previously, HIV testing and receiving test results (aOR = 2.00; 95% CI 1.50-2.66) and an age of 20-24 years versus 15-19 years (aOR = 1.54; 95% CI 1.20-1.96) were associated with increased odds of PrEP awareness. The odds of AYA endorsement of PrEP were higher among those aged 20-24 years versus 15-19 years (aOR = 1.39; 95% CI 1.07-1.83) and those who previously tested for HIV and received results (aOR = 1.97; 95% CI 1.43-2.72), but lower among female respondents (aOR = 0.66; 95% CI 0.49-0.88). PrEP awareness and endorsement among AYA in Tanzania were low, with nearly 7 in 100 aware of PrEP and 6 in 100 approving of its use. Targeted interventions focused on adolescents, females, and rural communities are needed to increase PrEP awareness and usage to achieve the Joint United Nations Programme on HIV/Acquired Immune Deficiency Syndrome (AIDS) (UNAIDS) 95-95-95 goals for HIV epidemic control.
暴露前预防(PrEP)是预防包括青少年和青年(AYA)在内的高危人群感染人类免疫缺陷病毒(HIV)的有效措施。本研究利用2022年坦桑尼亚人口与健康调查的数据,评估了PrEP知晓率和认可度以及与这些结果相关的因素。分析纳入了15至24岁的参与者。参与者被问及他们是否听说过预防HIV的每日用药(PrEP)以及是否赞成每日使用PrEP。还收集了人口统计学特征和HIV检测信息。采用逻辑回归模型评估与PrEP知晓率和认可度相关的因素,并计算这些结果的加权患病率。总共评估了8268名15至24岁的受访者,其中5852名(70.9%)为女性。总体而言,PrEP知晓率和认可度分别为6.9%(95%置信区间[CI]6.2 - 7.7)和5.7%(95%CI 5.1 - 6.4)。与男性受访者和城市居民相比,女性受访者(调整后的优势比[aOR]=0.69;95%CI 0.51 - 0.91)和农村居民(aOR = 0.78;95%CI 0.61 - 1.00)的PrEP知晓率较低。以前进行过HIV检测并收到检测结果(aOR = 2.00;95%CI 1.50 - 2.66)以及年龄在20 - 24岁而非15 - 19岁(aOR = 1.54;95%CI 1.20 - 1.96)与PrEP知晓率增加相关。与15 - 19岁的人群相比,20 - 24岁的AYA对PrEP的认可度较高(aOR = 1.39;95%CI 1.07 - 1.83),以及以前进行过HIV检测并收到结果的人群(aOR = 1.97;95%CI 1.43 - 2.72),但女性受访者的认可度较低(aOR = 0.66;95%CI 0.49 - 0.88)。坦桑尼亚AYA对PrEP的知晓率和认可度较低,每100人中近7人知晓PrEP,每100人中6人赞成使用PrEP。需要针对青少年、女性和农村社区开展有针对性的干预措施,以提高PrEP知晓率和使用率,实现联合国艾滋病规划署(UNAIDS)关于HIV疫情控制的95 - 95 - 95目标。